TCIM
KDNY

TIAA CREF Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

TIAA CREF Investment Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$513K Buy
25,793
+207
+0.8% +$3.61K ﹤0.01% 2590
2018
Q4 		$338K Sell
25,586
-18,350
-42% -$367K ﹤0.01% 2732
2018
Q3 		$1.61M Sell
43,936
-23,946
-35% -$769K ﹤0.01% 2229
2018
Q2 		$2.38M Buy
67,882
+34,199
+102% +$1.31M ﹤0.01% 2076
2018
Q1 		$1.57M Buy
33,683
+8,368
+33% +$306K ﹤0.01% 2234
2017
Q4 		$949K Buy
25,315
+3,847
+18% +$168K ﹤0.01% 2493
2017
Q3 		$1.14M Buy
21,468
+237
+1% +$14.1K ﹤0.01% 2456
2017
Q2 		$1.21M Buy
21,231
+1,542
+8% +$77.4K ﹤0.01% 2460
2017
Q1 		$1.06M Sell
19,689
-752
-4% -$42.5K ﹤0.01% 2483
2016
Q4 		$1.17M Sell
20,441
-9,004
-31% -$545K ﹤0.01% 2450
2016
Q3 		$1.83K Buy
29,445
+4,308
+17% +$305K ﹤0.01% 2229
2016
Q2 		$1.42M Buy
25,137
+19,623
+356% +$1.19M ﹤0.01% 2331
2016
Q1 		$353K Sell
5,514
-4,698
-46% -$380K ﹤0.01% 2881
2015
Q4 		$1.44M Buy
10,212
+4,698
+85% +$638K ﹤0.01% 2356
2015
Q3 		$534K Buy
5,514
+3,282
+147% +$391K ﹤0.01% 2867
2015
Q2 		$338K Buy
+2,232
New +$369K ﹤0.01% 3046

Other funds holding KDNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TIAA CREF Investment Management's KDNY Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 0.81% in Q1 2019, buying an estimated $3.61K and bringing the position to 25,793 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

TIAA CREF Investment Management first reported a position in KDNY in Q2 2015 and has held it in 16 quarters since. The position peaked at $2.38M in Q2 2018. 102 funds tracked by Wall St. Rank hold KDNY as of Q1 2019.

  • TIAA CREF Investment Management held 25,793 shares of Chinook Therapeutics, Inc. Common Stock worth $513K as of Q1 2019.
  • TIAA CREF Investment Management bought 207 Chinook Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $3.61K.
  • Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2590 holding.
  • TIAA CREF Investment Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 16 quarters since.
  • TIAA CREF Investment Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2.38M in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.